Spine-Tech (SPYN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Spine-Tech (SPYN)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Bruce Payne who wrote (90)	1/5/1997 3:18:00 PM
From: craig	of 242

Could someone take a look at this chart? Might be a good time to get in. Some news should be out this month or next month. J &J looking at them ??? Thanks Craig (SPSI) nasdaq SpectraSCIENCE receives 510(k) premarket notification clearance from United States Food and Drug Administration for fiberoptic Biopsy Forceps MINNEAPOLIS--(BUSINESS WIRE)--Dec. 16, 1996-- Spectrascience Inc announced today that the company has been notified by the United States Food and Drug Administration that it has received 510(k) premarket notification clearance for its fiberoptic Biopsy Forceps. The SpectraSCIENCE Biopsy Forceps is designed specifically to collect tissue samples utilizing minimally invasive endoscopic techniques for histopathological examination. The disposable product is intended for endoscopic gastrointestinal and urological biopsy applications. The SpectraSCIENCE Biopsy Forceps has an adjunctive feature incorporating a fiberoptic core for the transmission of light during tissue biopsy procedures. The Biopsy Forceps will be utilized during clinical studies to further advance the development of the electro-optic and software components of the SpectraSCIENCE Optical Biopsy(TM) System. SpectraSCIENCE believes that achievement of this significant milestone is an important step towards the clinical development of its Optical Biopsy(TM) System and the generation of revenues worldwide through institutional sales of its products. SpectraSCIENCE is a market driven early growth stage company located in Minneapolis, Minnesota, which applies advanced spectroscopic diagnostic techniques to the analysis of specific human tissues associated with important diseases. The company believes its technology will significantly impact the medical market, initially in cardiovascular medicine and the detection of cancer.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next